Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
6.42
-0.20 (-3.02%)
At close: Jul 11, 2025, 4:00 PM
6.41
-0.01 (-0.16%)
After-hours: Jul 11, 2025, 7:47 PM EDT
Bausch Health Companies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 9,616 | 9,518 | 8,663 | 8,025 | 8,328 | 7,924 | Upgrade
|
Other Revenue | 115 | 107 | 94 | 99 | 106 | 103 | Upgrade
|
| 9,731 | 9,625 | 8,757 | 8,124 | 8,434 | 8,027 | Upgrade
| |
Revenue Growth (YoY) | 8.53% | 9.91% | 7.79% | -3.68% | 5.07% | -6.67% | Upgrade
|
Cost of Revenue | 2,843 | 2,782 | 2,559 | 2,364 | 2,394 | 2,249 | Upgrade
|
Gross Profit | 6,888 | 6,843 | 6,198 | 5,760 | 6,040 | 5,778 | Upgrade
|
Selling, General & Admin | 3,356 | 3,283 | 2,895 | 2,531 | 2,492 | 2,367 | Upgrade
|
Research & Development | 608 | 616 | 604 | 529 | 465 | 452 | Upgrade
|
Other Operating Expenses | 28 | - | 1 | 1 | - | 1 | Upgrade
|
Operating Expenses | 5,051 | 4,976 | 4,577 | 4,276 | 4,332 | 4,465 | Upgrade
|
Operating Income | 1,837 | 1,867 | 1,621 | 1,484 | 1,708 | 1,313 | Upgrade
|
Interest Expense | -1,363 | -1,388 | -1,328 | -1,464 | -1,426 | -1,534 | Upgrade
|
Interest & Investment Income | 35 | 33 | 26 | 14 | 7 | 13 | Upgrade
|
Currency Exchange Gain (Loss) | -36 | -47 | -52 | -8 | 7 | -30 | Upgrade
|
EBT Excluding Unusual Items | 473 | 465 | 267 | 26 | 296 | -238 | Upgrade
|
Merger & Restructuring Charges | -26 | -36 | -95 | -68 | -73 | -23 | Upgrade
|
Impairment of Goodwill | - | - | -493 | -824 | -469 | - | Upgrade
|
Gain (Loss) on Sale of Assets | 6 | 10 | 3 | 5 | 2 | 1 | Upgrade
|
Asset Writedown | -28 | -29 | -45 | -10 | -211 | -112 | Upgrade
|
Legal Settlements | -214 | -220 | - | -9 | -356 | -422 | Upgrade
|
Other Unusual Items | -7 | -5 | -80 | 752 | -205 | -107 | Upgrade
|
Pretax Income | 189 | 167 | -390 | -129 | -1,024 | -934 | Upgrade
|
Income Tax Expense | 270 | 239 | 221 | 83 | -87 | -375 | Upgrade
|
Earnings From Continuing Operations | -81 | -72 | -611 | -212 | -937 | -559 | Upgrade
|
Minority Interest in Earnings | 41 | 26 | 19 | -13 | -11 | -1 | Upgrade
|
Net Income | -40 | -46 | -592 | -225 | -948 | -560 | Upgrade
|
Net Income to Common | -40 | -46 | -592 | -225 | -948 | -560 | Upgrade
|
Shares Outstanding (Basic) | 369 | 368 | 365 | 362 | 359 | 355 | Upgrade
|
Shares Outstanding (Diluted) | 369 | 368 | 365 | 362 | 359 | 355 | Upgrade
|
Shares Change (YoY) | 0.80% | 0.85% | 0.80% | 0.86% | 1.10% | 0.82% | Upgrade
|
EPS (Basic) | -0.11 | -0.13 | -1.62 | -0.62 | -2.64 | -1.58 | Upgrade
|
EPS (Diluted) | -0.11 | -0.13 | -1.62 | -0.62 | -2.64 | -1.58 | Upgrade
|
Free Cash Flow | 1,227 | 1,260 | 817 | -946 | 1,157 | 809 | Upgrade
|
Free Cash Flow Per Share | 3.33 | 3.42 | 2.24 | -2.61 | 3.22 | 2.28 | Upgrade
|
Gross Margin | 70.78% | 71.10% | 70.78% | 70.90% | 71.61% | 71.98% | Upgrade
|
Operating Margin | 18.88% | 19.40% | 18.51% | 18.27% | 20.25% | 16.36% | Upgrade
|
Profit Margin | -0.41% | -0.48% | -6.76% | -2.77% | -11.24% | -6.98% | Upgrade
|
Free Cash Flow Margin | 12.61% | 13.09% | 9.33% | -11.64% | 13.72% | 10.08% | Upgrade
|
EBITDA | 3,089 | 3,134 | 2,885 | 2,878 | 3,260 | 3,138 | Upgrade
|
EBITDA Margin | 31.74% | 32.56% | 32.95% | 35.43% | 38.65% | 39.09% | Upgrade
|
D&A For EBITDA | 1,252 | 1,267 | 1,264 | 1,394 | 1,552 | 1,825 | Upgrade
|
EBIT | 1,837 | 1,867 | 1,621 | 1,484 | 1,708 | 1,313 | Upgrade
|
EBIT Margin | 18.88% | 19.40% | 18.51% | 18.27% | 20.25% | 16.36% | Upgrade
|
Effective Tax Rate | 142.86% | 143.11% | - | - | - | - | Upgrade
|
Revenue as Reported | 9,731 | 9,625 | 8,757 | 8,124 | 8,434 | 8,027 | Upgrade
|
Updated Feb 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.